Why the study?
Xiao-Qing-Long Tang has anti-inflammatory and immune-regulating effects, but whether it prevents HFpEF development through modulation of the gut microbiota remained unknown.
Does Xiao-Qing-Long Tang prevent the development of HFpEF in model rats?
Does Xiao-Qing-Long Tang prevent the development of HFpEF in model rats?
Xiao-Qing-Long Tang prevents the development of HFpEF in a rat model by modulating the gut microbiota composition.
Answers are grounded in this paper and cite their sources.
May inform microbiota-targeted HFpEF strategies in models; leaves open human translation.
BACKGROUND: Changes in the gut microbiota are associated with cardiovascular disease progression. Xiao-Qing-Long Tang (XQLT), a traditional herbal formula, has an anti-inflammatory effect and regulates the steady state of the immune system, which is also associated with the progression of heart failure with preserved ejection faction (HFpEF). In this study, we investigated whether XQLT could contribute to prevent the development of HFpEF and whether the modulation of the gut microbiota by this herbal formula could be involved in such effect. METHODS: The gut microbiota, SCFAs, the histology/function of the heart, and systolic blood pressure were examined to evaluate the effect of XQLT on the gut microbiota and the progression of HFpEF after oral administration of XQLT to model rats. Furthermore, we evaluated, through fecal microbiota transplantation experiments, whether the favorable effects of XQLT could be mediated by the gut microbiota. RESULTS: Oral administration of XQLT contributed to the reduction of elevated blood pressure, inflammation, and compensatory hypertrophy, features that are associated with the progression of HFpEF. The gut microbiota composition, SCFA levels, and intestinal mucosal histology were improved after treatment with XQLT. Moreover, fecal transfer from XQLT-treated rats was sufficient to prevent the progression of HFpEF. CONCLUSIONS: These data suggested that XQLT prevented the development of HFpEF in model rats by regulating the composition of the gut microbiota.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: